Faculty of Veterinary Medicine, Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, Kyrkjevegen 332/334, 4325, Sandnes, Norway.
Department of Animal Health and Food Safety, Norwegian Veterinary Institute, P.O. Box 750 Sentrum, 0106, Oslo, Norway.
Parasit Vectors. 2018 Jul 5;11(1):394. doi: 10.1186/s13071-018-2976-4.
Coccidiosis due to Eimeria spp. infections in lambs causes increased mortality and substantial production losses, and anticoccidials are important for control of the infection. Anticoccidial resistance has been reported in poultry and swine, and we recently described reduced toltrazuril efficacy in ovine Eimeria spp. in some Norwegian sheep farms using a newly developed faecal oocyst count reduction test (FOCRT). The aim of the present study was to use a controlled efficacy trial to assess the efficacy of toltrazuril against a field isolate suspected of being resistant.
Twenty lambs, 17-22 days old and raised protected against exposure to coccidia, were infected with a field isolate of 100,000 Eimeria spp. oocysts. This isolate was obtained from a farm with a previously calculated drug efficacy of 56% (95% confidence interval: -433.9 to 96.6%). At day 7 post-infection, 10 of the lambs were orally treated with 20 mg/kg toltrazuril (Baycox Sheep vet., Bayer Animal Health), while the other 10 lambs (controls) were given physiological saline. Clinical examinations were conducted, and weight gains recorded. Daily faecal samples were scored for diarrhoea on a scale from 1 to 5, and oocyst excretion was determined using a modified McMaster technique. Oocysts were morphologically identified to species level. At 17-24 days post-infection, the lambs were euthanized and necropsied.
The tested Eimeria isolate was resistant against toltrazuril, and resistance was seen in both pathogenic and non-pathogenic species. In addition, no significant differences in faecal score, growth, gross pathology or histological changes were identified between the two groups. The pathogenic E. ovinoidalis was the dominant species, and no significant difference in the individual prevalence of E. ovinoidalis post-treatment was found between treated (66.9%) and control lambs (61.9%). Other species identified included E. crandallis/weybridgensis, E. parva, E. marsica, E. faurei, E. pallida, E. ahsata and E. bakuensis.
This study confirms toltrazuril resistance in ovine Eimeria spp.; in addition, the data support the use of FOCRT as an appropriate tool for field evaluation of anticoccidial efficacy. Due to limited anticoccidial treatment alternatives, these findings may have important implications for the sheep industry, particularly in northern Europe.
绵羊的艾美耳球虫感染导致死亡率增加和大量生产损失,抗球虫药对于控制感染非常重要。抗球虫药耐药性已在禽类和猪中报道,我们最近描述了在一些挪威绵羊养殖场中,使用新开发的粪便卵囊计数减少试验(FOCRT),绵羊艾美耳球虫对甲苯三嗪的疗效降低。本研究的目的是使用对照疗效试验来评估甲苯三嗪对疑似耐药的田间分离株的疗效。
20 只 17-22 天大的羔羊,在保护下饲养,避免接触球虫,用 100,000 个艾美耳球虫卵囊的田间分离株感染。该分离株来自一个先前计算出药物疗效为 56%(95%置信区间:-433.9 至 96.6%)的农场。在感染后第 7 天,10 只羔羊口服 20mg/kg 甲苯三嗪(Baycox Sheep vet.,拜耳动物保健)治疗,而其他 10 只羔羊(对照组)给予生理盐水。进行临床检查并记录体重增加。每天对粪便样本进行腹泻评分(1-5 分),并使用改良麦克马斯特技术确定卵囊排泄量。卵囊通过形态学鉴定到种的水平。在感染后 17-24 天,对羔羊进行安乐死和剖检。
测试的艾美耳球虫分离株对甲苯三嗪有抗药性,并且在致病性和非致病性种中都有抗药性。此外,两组之间的粪便评分、生长、大体病理学或组织学变化没有显著差异。致病性的艾美耳等孢球虫是主要种,治疗组(66.9%)和对照组(61.9%)羔羊在治疗后单个艾美耳等孢球虫的患病率无显著差异。其他鉴定的种包括艾美耳克拉氏球虫/韦布里奇球虫、柔嫩艾美耳球虫、马耳他艾美耳球虫、芬氏艾美耳球虫、苍白艾美耳球虫、阿氏艾美耳球虫和巴库艾美耳球虫。
本研究证实了绵羊艾美耳球虫对甲苯三嗪的耐药性;此外,这些数据支持使用 FOCRT 作为评估抗球虫药疗效的现场评估的合适工具。由于抗球虫药治疗选择有限,这些发现可能对绵羊业,特别是北欧的绵羊业具有重要意义。